Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Janux Therapeutics stock
Learn how to easily invest in Janux Therapeutics stock.
Janux Therapeutics is a biotechnology business based in the US. Janux Therapeutics shares (JANX) are listed on the NASDAQ and all prices are listed in US Dollars. Janux Therapeutics employs 60 staff and has a trailing 12-month revenue of around $8.6 million.
How to buy Janux Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – JANX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Janux Therapeutics stock price (NASDAQ: JANX)Use our graph to track the performance of JANX stocks over time.
Janux Therapeutics shares at a glance
|Latest market close||$11.53|
|52-week range||$9.39 - $23.64|
|50-day moving average||$17.80|
|200-day moving average||$14.64|
|Wall St. target price||$29.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.33|
Buy Janux Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Janux Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Janux Therapeutics price performance over time
Historical closes compared with the close of $11.53 from 2023-03-21
|1 week (2023-03-14)||-19.71%|
|1 month (2023-02-22)||-32.53%|
|3 months (2022-12-22)||-4.24%|
|6 months (2022-09-22)||-13.44%|
|1 year (2022-03-22)||-26.04%|
|2 years (2021-03-18)||N/A|
|3 years (2020-03-18)||N/A|
|5 years (2018-03-18)||N/A|
Janux Therapeutics financials
|Revenue TTM||$8.6 million|
|Gross profit TTM||$-44,829,000|
|Return on assets TTM||-11.27%|
|Return on equity TTM||-18.36%|
|Market capitalisation||$553.9 million|
TTM: trailing 12 months
Janux Therapeutics share dividends
We're not expecting Janux Therapeutics to pay a dividend over the next 12 months.
Janux Therapeutics overview
Janux Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops immunotherapies based on proprietary Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients suffering from cancer. Its lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. The company is also developing a TRACIr costimulatory bispecific product candidate against programmed death-ligand 1 and Cluster of Differentiation 28 designed to improve the anti-tumor activity of T cells. In addition, its PSMA-TRACTr is designed to target PSMA, a protein expressed in prostate cancer tumors and the vasculature of other tumors; EGFR-TRACTr is designed to target EGFR in various cancer types with multiple approved monoclonal antibodies; and TROP2-TRACTr is designed to target TROP2, a clinically validated anti-tumor target for which there is an approved anti-TROP2 antibody-drug conjugate. The company was incorporated in 2017 and is headquartered in San Diego, California. .
Janux Therapeutics in the news
7 Biotech Stocks That Could Be the Next Big Thing
Frequently asked questionsWhat percentage of Janux Therapeutics is owned by insiders or institutions?
Currently 10.959% of Janux Therapeutics shares are held by insiders and 101.586% by institutions. How many people work for Janux Therapeutics?
Latest data suggests 60 work at Janux Therapeutics. When does the fiscal year end for Janux Therapeutics?
Janux Therapeutics's fiscal year ends in December. Where is Janux Therapeutics based?
Janux Therapeutics's address is: 11099 North Torrey Pines Road, La Jolla, CA, United States, 92037 What is Janux Therapeutics's ISIN number?
Janux Therapeutics's international securities identification number is: US47103J1051
More guides on Finder
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert